» Articles » PMID: 37560538

Biotechnological Advances and Applications of Human Pluripotent Stem Cell-derived Heart Models

Overview
Date 2023 Aug 10
PMID 37560538
Authors
Affiliations
Soon will be listed here.
Abstract

In recent years, significant biotechnological advancements have been made in engineering human cardiac tissues and organ-like models. This field of research is crucial for both basic and translational research due to cardiovascular disease being the leading cause of death in the developed world. Additionally, drug-associated cardiotoxicity poses a major challenge for drug development in the pharmaceutical and biotechnological industries. Progress in three-dimensional cell culture and microfluidic devices has enabled the generation of human cardiac models that faithfully recapitulate key aspects of human physiology. In this review, we will discuss 3D pluripotent stem cell (PSC)-models of the human heart, such as engineered heart tissues and organoids, and their applications in disease modeling and drug screening.

Citing Articles

Progress of organoid platform in cardiovascular research.

Du X, Jia H, Chang Y, Zhao Y, Song J Bioact Mater. 2024; 40:88-103.

PMID: 38962658 PMC: 11220467. DOI: 10.1016/j.bioactmat.2024.05.043.


The new era of cardiovascular research: revolutionizing cardiovascular research with 3D models in a dish.

Yang Y, Yang H, Kiskin F, Zhang J Med Rev (2021). 2024; 4(1):68-85.

PMID: 38515776 PMC: 10954298. DOI: 10.1515/mr-2023-0059.

References
1.
Kofron C, Kim T, Munarin F, Soepriatna A, Kant R, Mende U . A predictive in vitro risk assessment platform for pro-arrhythmic toxicity using human 3D cardiac microtissues. Sci Rep. 2021; 11(1):10228. PMC: 8119415. DOI: 10.1038/s41598-021-89478-9. View

2.
Blinova K, Stohlman J, Vicente J, Chan D, Johannesen L, Hortigon-Vinagre M . Comprehensive Translational Assessment of Human-Induced Pluripotent Stem Cell Derived Cardiomyocytes for Evaluating Drug-Induced Arrhythmias. Toxicol Sci. 2016; 155(1):234-247. PMC: 6093617. DOI: 10.1093/toxsci/kfw200. View

3.
Tadano K, Miyagawa S, Takeda M, Tsukamoto Y, Kazusa K, Takamatsu K . Cardiotoxicity assessment using 3D vascularized cardiac tissue consisting of human iPSC-derived cardiomyocytes and fibroblasts. Mol Ther Methods Clin Dev. 2021; 22:338-349. PMC: 8408525. DOI: 10.1016/j.omtm.2021.05.007. View

4.
Basara G, Gulberk Ozcebe S, Ellis B, Zorlutuna P . Tunable Human Myocardium Derived Decellularized Extracellular Matrix for 3D Bioprinting and Cardiac Tissue Engineering. Gels. 2021; 7(2). PMC: 8293197. DOI: 10.3390/gels7020070. View

5.
Shao Y, Taniguchi K, Gurdziel K, Townshend R, Xue X, Aw Yong K . Self-organized amniogenesis by human pluripotent stem cells in a biomimetic implantation-like niche. Nat Mater. 2016; 16(4):419-425. PMC: 5374007. DOI: 10.1038/nmat4829. View